Riliprubart is an immunoglobulin G4 humanized antibody that is designed to selectively inhibit activated C1s in the classical complement pathway of the innate immune system.

Benlysta is supplied as a single-dose prefilled autoinjector or prefilled syringe containing 200mg/mL of belimumab for SC use. The prefilled syringe has not been studied in pediatric patients aged ...

HealthDay News — Electroconvulsive therapy (ECT) shows a significant protective effect against suicide and overall mortality in people with depression, according to a review published online June 12 ...

HealthDay News — US drug overdose deaths (DODs) started declining in 2023, with a faster decline for opioid-related versus stimulant-related DOD rates, according to a study published online June 12 in ...

The Food and Drug Administration (FDA) has approved Harliku ™ (nitisinone) for the reduction of urine homogentisic acid (HGA) in adult patients with alkaptonuria.

The Food and Drug Administration (FDA) has granted accelerated approval to Datroway ® (datopotamab deruxtecan-dlnk) for adults with locally advanced or metastatic epidermal growth factor receptor ...

ST-100 is a novel collagen mimetic peptide designed to repair damaged collagen in the eye and restore homeostatic cell signaling in the ocular epithelium.

HealthDay News — Hypertension is the most common chronic condition among adults aged 85 years and older, with prevalence higher among women than men, according to a report published in the June Health ...

Lower risks for anxiety disorders, substance use disorders, cognitive deficits seen for those undergoing metabolic and bariatric surgery ...

Sustained reduction seen in body weight versus placebo for adults aged 18 to 75 with overweight or obesity, without diabetes ...

Topline results were announced from a phase 3 study evaluating sotatercept-csrk in recently diagnosed adults with pulmonary arterial hypertension (PAH).

Direct access to Wegovy® (semaglutide) will no longer be available through Hims & Hers Health, as Novo Nordisk has ended its short-lived partnership ...